Scientists have, for the first time, utilized artificial intelligence to design and create completely new viruses. These viruses, known as bacteriophages, are capable of replication but specifically target and infect *E. coli* bacteria, posing no threat to humans. The scientific community is hailing this achievement as a pivotal moment, describing it as a “turning point” and a “significant milestone” in biological research. This development marks the beginning of truly designing biology, rather than simply observing it. Researchers believe this capability could lead to advancements in combating antibiotic-resistant bacteria and developing new therapies. However, experts are also carefully considering the potential risks associated with creating novel biological agents, emphasizing the need for responsible innovation and oversight. The breakthrough opens exciting but complex new avenues in biotechnology.